PHIOGEN has developed a world-first technology platform for bacteriophages. This technology mobilizes the natural power of phages to tackle critical and life-threatening infections, marking a significant medical breakthrough for countering the global threat of antimicrobial resistance.
News
A collaborative project focused on bacteriophages to fight diseases in trout farming by the University of Copenhagen, the Technical University of Denmark, the Danish Technological Institute, DanAqua, KSK Aqua, Aller Aqua, Carus Animal Health and Fixed Phage.
The discovery of a phage with an extremely long tail, P74-26, or the Rapunzel bacteriophage, by researchers from the University of Massachusetts Chan Medical School, has given deeper insights into bacteriophage biology.
Healthcare Improvement Scotland Bacteriophage therapy for patients with difficult to treat bacterial infections recommendations for NHS Scotland.
UK Phage Therapy announces a collaboration with CPI, Fixed Phage, and the University of Leicester to establish Phage therapy infrastructure in the UK.
- News
BioChimPharm renovates the world’s oldest Phage factory – Revolutionizing access to Phage therapy
BioChimPharm, a Georgian biopharmaceutical company, announces the completion of the modernization and renovation of its historic phage manufacturing facility, which was originally built in 1934.
Fixed Phage secures further £1.5m investment to scale programmes in Animal & Veterinary Health and Human Health.
MicroMir shares results for the efficiency of oral and inhalation bacteriophage cocktails in their Post-Covid phage therapy rehabilitation study.
Phage-UK is now live. It is a network for clinicians and phage researchers that work together to help build a path for phage therapy to be accessible to patient based in the United Kingdom.
Creative Biolabs provides an overview of a study that looks into the possibility of bacteriophages monitoring their hosts.